Literature DB >> 8342142

Molecular mechanisms of decreased interleukin-2 production after thermal injury.

D S O'Riordain1, M V Mendez, M G O'Riordain, R G Molloy, R G Holzheimer, K Collins, I Saporoschetz, J A Mannick, M L Rodrick.   

Abstract

BACKGROUND: Among the fundamental immunologic abnormalities induced by serious traumatic or thermal injury are alterations in T cell activation, reduced lymphocyte interleukin-2 (IL-2) production, and associated depression of T lymphocyte proliferation. This study attempts to localize the cellular mechanisms underlying abnormal IL-2 production in thermal injury.
METHODS: Following National Institutes of Health guidelines, 150 A/J mice were anesthetized, subjected to a 20% full-thickness scald burn injury or sham burn, and killed at intervals from 4 to 21 days later; splenocytes were harvested for in vitro studies. For measurement of IL-2 production, cells were cultured with either concanavalin A or a combination of the phorbol ester PMA, which directly activates protein kinase C, and the calcium ionophore A23187, which increases intracellular calcium. Cytokine mRNA expression was measured by Northern blot analysis and IL-2 production by bioassay.
RESULTS: Both IL-2 production and IL-2 mRNA expression were consistently suppressed in concanavalin A-stimulated cells from burned mice compared with sham burns. This suppression of IL-2 and IL-2 mRNA also occurred when T cells were activated with PMA and A23187, bypassing the earlier stages of the signal transduction mechanism. IL-1 beta and tumor necrosis factor-alpha mRNA expression were consistently increased in burned animals, indicating that decreased IL-2 mRNA expression was specific to IL-2 and not representative of a global decrease in cytokine mRNA expression.
CONCLUSIONS: These results suggest that the principal cellular abnormalities that result in altered T cell activation and IL-2 production after thermal injury lie downstream of the initiating signal transduction events and before IL-2 gene transcription.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8342142

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  7 in total

1.  Development of an immunoassay kit for detecting the alteration of serum B cell activating factor in thermally injured mice.

Authors:  Guangyu Chen; Hongwu Du; Donggang Xu; Shanyun Peng; Jiaxi Wang
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

2.  Altered gene transcription after burn injury results in depressed T-lymphocyte activation.

Authors:  A F Horgan; M V Mendez; D S O'Riordain; R G Holzheimer; J A Mannick; M L Rodrick
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

3.  Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection.

Authors:  S T O'Sullivan; J A Lederer; A F Horgan; D H Chin; J A Mannick; M L Rodrick
Journal:  Ann Surg       Date:  1995-10       Impact factor: 12.969

4.  Stimulation of hematopoiesis by the Fms-like tyrosine kinase 3 ligand restores bacterial induction of Th1 cytokines in thermally injured mice.

Authors:  Tracy E Toliver-Kinsky; Cheng Y Lin; David N Herndon; Edward R Sherwood
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

5.  The use of growth factors and other humoral agents to accelerate and enhance burn wound healing.

Authors:  Yiu-Hei Ching; Thomas L Sutton; Yvonne N Pierpont; Martin C Robson; Wyatt G Payne
Journal:  Eplasty       Date:  2011-11-07

Review 6.  The cytokine response to physical activity and training.

Authors:  A I Moldoveanu; R J Shephard; P N Shek
Journal:  Sports Med       Date:  2001-02       Impact factor: 11.136

7.  Scald Injury-Induced T Cell Dysfunction Can Be Mitigated by Gr1+ Cell Depletion and Blockage of CD47/CD172a Signaling.

Authors:  Nadine Beckmann; Franziska Huber; Marc Hanschen; Barbara St Pierre Schneider; Vanessa Nomellini; Charles C Caldwell
Journal:  Front Immunol       Date:  2020-05-08       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.